United Therapeutic
(UTHR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Sales | 73,590 | 53,341 | 30,120 | 5,731 | 2,049 |
| Cost of Goods | 8,250 | 6,783 | 5,456 | 3,137 | 1,626 |
| Gross Profit | 65,340 | 46,558 | 24,664 | 2,594 | 423 |
| Operating Expenses | 52,381 | 58,867 | 43,123 | 49,670 | 82,550 |
| Operating Income | 13,209 | -11,526 | -18,003 | -46,939 | -81,501 |
| Interest Expense | 4 | 112 | 117 | 173 | 120 |
| Other Income | 2,244 | 1,669 | -5,531 | 9,824 | 6,012 |
| Pre-tax Income | 15,449 | -9,969 | -23,651 | -37,288 | -75,609 |
| Net Income Continuous | 15,449 | -9,969 | -23,651 | -37,288 | -75,609 |
| Net Income | $15,449 | $-9,969 | $-23,651 | $-37,288 | $-75,609 |
| EPS Basic Total Ops | 0.36 | -0.24 | -0.58 | -0.92 | -1.97 |
| EPS Basic Continuous Ops | 0.36 | -0.24 | -0.57 | -0.92 | -1.97 |
| EPS Diluted Total Ops | 0.33 | -0.24 | -0.58 | -0.92 | -1.97 |
| EPS Diluted Continuous Ops | 0.33 | -0.24 | -0.57 | -0.92 | -1.97 |
| EBITDA(a) | $15,485 | $-9,201 | $-14,868 | $-43,424 | $-81,580 |